Your browser doesn't support javascript.
loading
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
Philippe, Aurélien; Chocron, Richard; Gendron, Nicolas; Bory, Olivier; Beauvais, Agathe; Peron, Nicolas; Khider, Lina; Guerin, Coralie L; Goudot, Guillaume; Levasseur, Françoise; Peronino, Christophe; Duchemin, Jerome; Brichet, Julie; Sourdeau, Elise; Desvard, Florence; Bertil, Sébastien; Pene, Frédéric; Cheurfa, Cherifa; Szwebel, Tali-Anne; Planquette, Benjamin; Rivet, Nadia; Jourdi, Georges; Hauw-Berlemont, Caroline; Hermann, Bertrand; Gaussem, Pascale; Mirault, Tristan; Terrier, Benjamin; Sanchez, Olivier; Diehl, Jean-Luc; Fontenay, Michaela; Smadja, David M.
Afiliação
  • Philippe A; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Chocron R; Université de Paris, PARCC, INSERM, Emergency Department, Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Gendron N; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Bory O; Université de Paris, Emergency department, Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Beauvais A; Université de Paris, Emergency department, Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Peron N; Université de Paris, Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Khider L; Université de Paris, Vascular Medicine Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Guerin CL; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Curie Institute, Cytometry department, 75006, Paris, France.
  • Goudot G; Université de Paris, Vascular Medicine Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Levasseur F; Université de Paris, Institut Cochin, INSERM, 75014, Paris, France.
  • Peronino C; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Duchemin J; Hematology Department, Assistance Publique-Hôpitaux de Paris. Centre-Université de Paris (AP-HP.CUP), Cochin Hospital, 75014, Paris, France.
  • Brichet J; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Sourdeau E; Emergency department, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Hôtel-Dieu Hospital, 75014, Paris, France.
  • Desvard F; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Bertil S; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Pene F; Intensive Care Medicine and Reanimation Department, Assistance Publique-Hôpitaux de Paris.Centre-Université de Paris (AP-HP.CUP), Cochin Hospital, 75014, Paris, France.
  • Cheurfa C; Anaesthesia, Intensive Care and Perioperative Medicine Department, GHU AP-HP, Centre - Université de Paris - Cochin Hospital, 75014, Paris, France.
  • Szwebel TA; Internal Medicine Department, AP-HP.Centre - Université de Paris - Cochin Hospital, 75014, Paris, France.
  • Planquette B; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Respiratory Medicine Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Rivet N; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Jourdi G; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department Assistance Publique Hôpitaux de Paris.Centre-Université de Paris (APHP-CUP), 75014, Paris, France.
  • Hauw-Berlemont C; Université de Paris, Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Hermann B; Université de Paris, Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Gaussem P; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France.
  • Mirault T; Université de Paris, PARCC, INSERM, 75015 Paris, France, Vascular medicine department, Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Terrier B; Université de Paris, PARCC, INSERM U970, 75015 Paris, France, Internal Medicine Department, AH-HP-Centre Université de Paris (CUP), 75014, Paris, France.
  • Sanchez O; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Respiratory Medicine Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Diehl JL; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Intensive Care Unit and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP), 75015, Paris, France.
  • Fontenay M; Université de Paris, Institut Cochin, INSERM, 75014 Paris, France, Hematology Department Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP-CUP), Cochin Hospital, 75014, Paris, France.
  • Smadja DM; Université de Paris, Innovative Therapies in Haemostasis, INSERM, 75006 Paris, France, Hematology Department and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP), 20 rue Leblanc, 75015, Paris, France. david.smadja@aphp.fr.
Angiogenesis ; 24(3): 505-517, 2021 08.
Article em En | MEDLINE | ID: mdl-33449299

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Pandemias / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Pandemias / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article